Clinical Trials Browser

Completed × Neurotoxicity Syndromes × Breast × Clear all

NCT04583124 2025-11-18

ATENTO

Phase NA Completed

Breast Neoplasms, Neurotoxicity Syndromes

NCT00039780 2022-07-13

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Phase 3 Completed

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Paresthesia, Neurotoxicity Syndromes

NCT02864030 2021-03-04

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Phase 4 Completed

Breast Neoplasms, Neurotoxicity Syndromes, Drug-Related Side Effects and Adverse Reactions

NCT00755313 2017-11-24

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT00775645 2017-08-14

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Phase 3 Completed

437 enrolled 14 charts

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT01982591 2017-06-15

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Breast Neoplasms, Peripheral Nervous System Diseases, Breast Neoplasms, Male, Neurotoxicity Syndromes

NCT00046891 2016-07-06

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

Phase 3 Completed

226 enrolled 12 charts

Breast Neoplasms, Neurotoxicity Syndromes

NCT01763710 2016-03-29

neurabrax

Phase 2 Completed

Breast Neoplasms, Neurotoxicity Syndromes

NCT00078845 2012-10-17

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Phase 2 Completed

BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Neurotoxicity Syndromes, Small Cell Lung Carcinoma